Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 229

Results For "India"

3568 News Found

Telemedicine service eSanjeevani achieves 8 crore teleconsultations
News | December 07, 2022

Telemedicine service eSanjeevani achieves 8 crore teleconsultations

The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform


Briefs: Natco Pharma & Lupin
News | December 06, 2022

Briefs: Natco Pharma & Lupin

Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.


Apollo Conclave 2022 highlights role of research in driving better clinical outcomes
News | December 06, 2022

Apollo Conclave 2022 highlights role of research in driving better clinical outcomes

The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.


JB Pharma reduces price of Azmarda by 50%
News | December 06, 2022

JB Pharma reduces price of Azmarda by 50%

Move to increase affordability and accessibility for heart failure patients across the country


ANSSI Wellness inaugurates its new spine clinic in Pune
Healthcare | December 06, 2022

ANSSI Wellness inaugurates its new spine clinic in Pune

Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune


ASG Eye Hospitals opens hospital in Vashi
Healthcare | December 06, 2022

ASG Eye Hospitals opens hospital in Vashi

The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra


Auretics launched herbal cough syrup ‘Sedoril’
News | December 06, 2022

Auretics launched herbal cough syrup ‘Sedoril’

It offers quick relief in various types of Coughs, Colds and Sore Throat,


Zydus receives final approval from USFDA for Estradiol Transdermal System
Drug Approval | December 05, 2022

Zydus receives final approval from USFDA for Estradiol Transdermal System

The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad


Orchid Pharma launches Rs. 500 Cr QIP programme
News | December 02, 2022

Orchid Pharma launches Rs. 500 Cr QIP programme

With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023


Alembic receives USFDA final approval for Diclofenac Sodium Topical Solution USP
Drug Approval | December 02, 2022

Alembic receives USFDA final approval for Diclofenac Sodium Topical Solution USP

Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA